Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Awake thoracic epidural anesthesia (TEA) is a regional anesthetic technique used for patients undergoing major thoracic surgery, such as thoracotomy, without the requirement for general anesthesia or endotracheal intubation. In the specific context of the Cairo University clinical trial, this intervention involves the administration of **bupivacaine** into the thoracic epidural space. This approach allows the patient to remain conscious and maintain spontaneous ventilation throughout the procedure, which may reduce the incidence of complications associated with general anesthesia, such as ventilator-induced lung injury and hemodynamic instability. The technique is primarily indicated for patients undergoing thoracotomy where avoiding the systemic effects of general anesthetics and muscle relaxants is beneficial.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Awake thoracic epidural anesthesia.